These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 19440075

  • 1. Zolpidem extended-release improves sleep and next-day symptoms in comorbid insomnia and generalized anxiety disorder.
    Fava M, Asnis GM, Shrivastava R, Lydiard B, Bastani B, Sheehan D, Roth T.
    J Clin Psychopharmacol; 2009 Jun; 29(3):222-30. PubMed ID: 19440075
    [Abstract] [Full Text] [Related]

  • 2. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial.
    Fava M, Asnis GM, Shrivastava RK, Lydiard B, Bastani B, Sheehan DV, Roth T.
    J Clin Psychiatry; 2011 Jul; 72(7):914-28. PubMed ID: 21208597
    [Abstract] [Full Text] [Related]

  • 3. Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder.
    Pollack M, Kinrys G, Krystal A, McCall WV, Roth T, Schaefer K, Rubens R, Roach J, Huang H, Krishnan R.
    Arch Gen Psychiatry; 2008 May; 65(5):551-62. PubMed ID: 18458207
    [Abstract] [Full Text] [Related]

  • 4. Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study.
    Krystal AD, Erman M, Zammit GK, Soubrane C, Roth T, ZOLONG Study Group.
    Sleep; 2008 Jan; 31(1):79-90. PubMed ID: 18220081
    [Abstract] [Full Text] [Related]

  • 5. Zolpidem for persistent insomnia in SSRI-treated depressed patients.
    Asnis GM, Chakraburtty A, DuBoff EA, Krystal A, Londborg PD, Rosenberg R, Roth-Schechter B, Scharf MB, Walsh JK.
    J Clin Psychiatry; 1999 Oct; 60(10):668-76. PubMed ID: 10549683
    [Abstract] [Full Text] [Related]

  • 6. Comparison of Lemborexant With Placebo and Zolpidem Tartrate Extended Release for the Treatment of Older Adults With Insomnia Disorder: A Phase 3 Randomized Clinical Trial.
    Rosenberg R, Murphy P, Zammit G, Mayleben D, Kumar D, Dhadda S, Filippov G, LoPresti A, Moline M.
    JAMA Netw Open; 2019 Dec 02; 2(12):e1918254. PubMed ID: 31880796
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
    Roth T, Soubrane C, Titeux L, Walsh JK, Zoladult Study Group.
    Sleep Med; 2006 Aug 02; 7(5):397-406. PubMed ID: 16815744
    [Abstract] [Full Text] [Related]

  • 8. Hypnotics in insomnia: the experience of zolpidem.
    MacFarlane J, Morin CM, Montplaisir J.
    Clin Ther; 2014 Nov 01; 36(11):1676-701. PubMed ID: 25455931
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of a polyherbal sedative-hypnotic formulation NSF-3 in primary insomnia in comparison to zolpidem: a randomized controlled trial.
    Maroo N, Hazra A, Das T.
    Indian J Pharmacol; 2013 Nov 01; 45(1):34-9. PubMed ID: 23543804
    [Abstract] [Full Text] [Related]

  • 10. Zolpidem extended-release: a single insomnia treatment option for sleep induction and sleep maintenance symptoms.
    Barkin RL.
    Am J Ther; 2007 Nov 01; 14(3):299-305. PubMed ID: 17515707
    [Abstract] [Full Text] [Related]

  • 11. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
    Pelissolo A.
    Encephale; 2008 Sep 01; 34(4):400-8. PubMed ID: 18922243
    [Abstract] [Full Text] [Related]

  • 12. Novel sublingual low-dose zolpidem tablet reduces latency to sleep onset following spontaneous middle-of-the-night awakening in insomnia in a randomized, double-blind, placebo-controlled, outpatient study.
    Roth T, Krystal A, Steinberg FJ, Singh NN, Moline M.
    Sleep; 2013 Feb 01; 36(2):189-96. PubMed ID: 23372266
    [Abstract] [Full Text] [Related]

  • 13. A post hoc analysis of the effect of nightly administration of eszopiclone and a selective serotonin reuptake inhibitor in patients with insomnia and anxious depression.
    Fava M, Schaefer K, Huang H, Wilson A, Iosifescu DV, Mischoulon D, Wessel TC.
    J Clin Psychiatry; 2011 Apr 01; 72(4):473-9. PubMed ID: 21208574
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of zolpidem extended release in elderly primary insomnia patients.
    Walsh JK, Soubrane C, Roth T.
    Am J Geriatr Psychiatry; 2008 Jan 01; 16(1):44-57. PubMed ID: 18165461
    [Abstract] [Full Text] [Related]

  • 15. A polysomnographic placebo-controlled evaluation of the efficacy and safety of eszopiclone relative to placebo and zolpidem in the treatment of primary insomnia.
    Erman MK, Zammit G, Rubens R, Schaefer K, Wessel T, Amato D, Caron J, Walsh JK.
    J Clin Sleep Med; 2008 Jun 15; 4(3):229-34. PubMed ID: 18595435
    [Abstract] [Full Text] [Related]

  • 16. [Treatment of insomnia related to depressive disorders. Effects of zolpidem versus flunitrazepam administration and withdrawal evaluated in a double-blind study].
    Guazzelli M, Ciapparelli A, Balsamo EL, Gemignani A, Sarteschi P.
    Minerva Psichiatr; 1993 Sep 15; 34(3):193-203. PubMed ID: 8302193
    [Abstract] [Full Text] [Related]

  • 17. Zolpidem in the treatment of transient insomnia: a double-blind, randomized comparison with placebo.
    Roth T, Roehrs T, Vogel G.
    Sleep; 1995 May 15; 18(4):246-51. PubMed ID: 7618022
    [Abstract] [Full Text] [Related]

  • 18. Effect of zolpidem on sleep in women with perimenopausal and postmenopausal insomnia: a 4-week, randomized, multicenter, double-blind, placebo-controlled study.
    Dorsey CM, Lee KA, Scharf MB.
    Clin Ther; 2004 Oct 15; 26(10):1578-86. PubMed ID: 15598474
    [Abstract] [Full Text] [Related]

  • 19. Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies.
    Clayton AH, Croft HA, Horrigan JP, Wightman DS, Krishen A, Richard NE, Modell JG.
    J Clin Psychiatry; 2006 May 15; 67(5):736-46. PubMed ID: 16841623
    [Abstract] [Full Text] [Related]

  • 20. Nonorganic insomnia in generalized anxiety disorder. 2. Comparative studies on sleep, awakening, daytime vigilance and anxiety under lorazepam plus diphenhydramine (Somnium) versus lorazepam alone, utilizing clinical, polysomnographic and EEG mapping methods.
    Saletu B, Saletu-Zyhlarz G, Anderer P, Brandstätter N, Frey R, Gruber G, Klösch G, Mandl M, Grünberger J, Linzmayer L.
    Neuropsychobiology; 1997 May 15; 36(3):130-52. PubMed ID: 9313245
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.